Genetically mutated cancer cells grow may help explain why patients with a common form of leukemia develop treatment resistance, according to new Weill Cornell Medicine research.
Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.
A Cornell research group reports that a mechanical factor - stiffening of a cancer cell and its matrix - and not a chemical cause could contribute to metastasis in some forms of cancer.
The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.
Six new technologies received 2013 Center for Advanced Technology awards for feasibility and proof-of-concept research to enhance the commercial value of such innovations.
Twenty students, faculty and staff members in Cornell’s contract colleges have won State University of New York Chancellor’s Awards for Excellence for 2014.
Cornell University will partner with the Democratic Republic of the Congo’s Eben-Ezer University of Minembwe to offer two virtual courses, one on peace building and another on African disease patterns.